TY - JOUR
T1 - Cut-offs for calf circumference as a screening tool for low muscle mass
T2 - WASEDA'S Health Study
AU - Kawakami, Ryoko
AU - Miyachi, Motohiko
AU - Sawada, Susumu S.
AU - Torii, Suguru
AU - Midorikawa, Taishi
AU - Tanisawa, Kumpei
AU - Ito, Tomoko
AU - Usui, Chiyoko
AU - Ishii, Kaori
AU - Suzuki, Katsuhiko
AU - Sakamoto, Shizuo
AU - Higuchi, Mitsuru
AU - Muraoka, Isao
AU - Oka, Koichiro
N1 - Funding Information:
The authors would like to thank the study participants. We are also grateful to the staff of WASEDA'S Health Study, for their invaluable advice and assistance with data collection. This work was supported by a Grant‐in‐Aid for Early‐Career Scientists (JP18K17982) and for Scientific Research (JP19H04008, JP26242070) from the Japan Society for the Promotion of Science; MEXT‐Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (S1511017); and a Waseda University Grant for Special Research Projects (2019C‐368).
Publisher Copyright:
© 2020 The Authors. Geriatrics & Gerontology International published by John Wiley & Sons Australia, Ltd on behalf of Japan Geriatrics Society.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Aim: To re-evaluate the suitability of calf circumference as a surrogate marker of low muscle mass measured by both bioelectrical impedance analysis (BIA) and dual-energy X-ray absorptiometry (DXA). We also examined the effects of obesity and age on low muscle mass screening using calf circumference. Methods: In total, 1239 adults participated in this cross-sectional study. We measured the maximum calf circumference in a standing position and appendicular skeletal muscle mass (ASM) using BIA and DXA. We defined low muscle mass based on the Asian Working Group for Sarcopenia 2019 consensus. Results: Calf circumference was positively correlated with BIA-measured ASM/height2 (men: r = 0.81, women: r = 0.73) and DXA-measured ASM/height2 (men: r = 0.78, women: r = 0.76). In the subgroup analyses by obesity and age, calf circumference was also positively correlated with ASM/height2. The optimal calf circumference cut-offs for low muscle mass screening measured by BIA and DXA were 35 cm (sensitivity 91%, specificity 84%) and 36 cm (sensitivity 82%, specificity 80%) for men, and 33 cm (sensitivity 82%, specificity 84%) and 34 cm (sensitivity 85%, specificity 72%) for women, respectively. Conclusions: Calf circumference is positively correlated with BIA- and DXA-measured muscle mass regardless of obesity and age and is a simple and accurate surrogate marker of muscle mass for diagnosing sarcopenia. Geriatr Gerontol Int 2020; 20: 943–950.
AB - Aim: To re-evaluate the suitability of calf circumference as a surrogate marker of low muscle mass measured by both bioelectrical impedance analysis (BIA) and dual-energy X-ray absorptiometry (DXA). We also examined the effects of obesity and age on low muscle mass screening using calf circumference. Methods: In total, 1239 adults participated in this cross-sectional study. We measured the maximum calf circumference in a standing position and appendicular skeletal muscle mass (ASM) using BIA and DXA. We defined low muscle mass based on the Asian Working Group for Sarcopenia 2019 consensus. Results: Calf circumference was positively correlated with BIA-measured ASM/height2 (men: r = 0.81, women: r = 0.73) and DXA-measured ASM/height2 (men: r = 0.78, women: r = 0.76). In the subgroup analyses by obesity and age, calf circumference was also positively correlated with ASM/height2. The optimal calf circumference cut-offs for low muscle mass screening measured by BIA and DXA were 35 cm (sensitivity 91%, specificity 84%) and 36 cm (sensitivity 82%, specificity 80%) for men, and 33 cm (sensitivity 82%, specificity 84%) and 34 cm (sensitivity 85%, specificity 72%) for women, respectively. Conclusions: Calf circumference is positively correlated with BIA- and DXA-measured muscle mass regardless of obesity and age and is a simple and accurate surrogate marker of muscle mass for diagnosing sarcopenia. Geriatr Gerontol Int 2020; 20: 943–950.
KW - anthropometry
KW - bioelectrical impedance
KW - body composition
KW - dual-energy X-ray absorptiometry scan
KW - sarcopenia
UR - http://www.scopus.com/inward/record.url?scp=85090125506&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090125506&partnerID=8YFLogxK
U2 - 10.1111/ggi.14025
DO - 10.1111/ggi.14025
M3 - Article
C2 - 32886830
AN - SCOPUS:85090125506
SN - 1444-1586
VL - 20
SP - 943
EP - 950
JO - Geriatrics and Gerontology International
JF - Geriatrics and Gerontology International
IS - 10
ER -